FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis

Transplant Proc. 1996 Dec;28(6):3166-8.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Anti-Infective Agents / therapeutic use*
  • Azathioprine / therapeutic use
  • Contraindications
  • Creatinine / blood
  • Dose-Response Relationship, Drug
  • Drug Resistance
  • Female
  • Follow-Up Studies
  • Ganciclovir / therapeutic use
  • Graft Rejection / drug therapy*
  • Graft Rejection / immunology
  • Graft Survival
  • Hepatitis B / complications
  • Hepatitis C / complications
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / physiology
  • Male
  • Muromonab-CD3 / therapeutic use
  • Steroids / therapeutic use
  • Tacrolimus / therapeutic use*
  • Time Factors
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Anti-Infective Agents
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Steroids
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Creatinine
  • Azathioprine
  • Ganciclovir
  • Tacrolimus